Cyclopharm Limited (ASX:CYC) Insider Buys A$50,754.00 in Stock

Cyclopharm Limited (ASX:CYC) insider John Wigglesworth acquired 33,000 shares of the firm’s stock in a transaction that occurred on Monday, September 30th. The shares were purchased at an average price of A$1.54 ($1.06) per share, with a total value of A$50,754.00 ($35,002.76).

Cyclopharm Stock Performance

The company has a quick ratio of 4.68, a current ratio of 4.38 and a debt-to-equity ratio of 11.72.

Cyclopharm Company Profile

Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally. The company operates through Technegas and Molecular Imaging segments. The Technegas segment offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism.